NDC Package 25021-820-05 Methylprednisolone Acetate

Injection, Suspension Intra-articular; Intralesional; Intramuscular; Intrasynovial; Soft - View Billable Units, 11-Digit Format, RxNorm

Package Information

Find all the important details about this NDC Package code, including the 11-Digit NDC Billing number, billing units, wholesale price, RxNorm crosswalk, active ingredients, pharmacologic clasess, etc.

NDC Package Code:
25021-820-05
Package Description:
1 VIAL in 1 CARTON / 5 mL in 1 VIAL
Product Code:
Proprietary Name:
Methylprednisolone Acetate
Non-Proprietary Name:
Methylprednisolone Acetate
Substance Name:
Methylprednisolone Acetate
Usage Information:
Methylprednisolone is used to treat pain and swelling that occurs with arthritis and other joint disorders. This medication may also be used to treat various conditions such as blood disorders, severe allergic reactions, certain cancers, eye conditions, skin/intestinal/kidney/lung diseases, and immune system disorders. It decreases your immune system's response to these conditions and reduces symptoms such as swelling, pain, and allergic-type reactions. Talk to your doctor about the risks and benefits of methylprednisolone, especially if it is to be injected near your spine (epidural). Rare but serious side effects may occur with epidural use. Methylprednisolone is a corticosteroid hormone. Methylprednisolone may also be used with other medications in hormone disorders.
11-Digit NDC Billing Format:
25021082005
Billing Unit:
ML - Billing unit of "milliliter" is used when a product is measured by its liquid volume.
NDC to RxNorm Crosswalk:
  • RxCUI: 1358610 - methylPREDNISolone acetate 40 MG/ML Injectable Suspension
  • RxCUI: 1358610 - methylprednisolone acetate 40 MG/ML Injectable Suspension
  • RxCUI: 1358617 - methylPREDNISolone acetate 80 MG/ML Injectable Suspension
  • RxCUI: 1358617 - methylprednisolone acetate 80 MG/ML Injectable Suspension
  • Product Type:
    Human Prescription Drug
    Labeler Name:
    Sagent Pharmaceuticals
    Dosage Form:
    Injection, Suspension - A liquid preparation, suitable for injection, which consists of solid particles dispersed throughout a liquid phase in which the particles are not soluble. It can also consist of an oil phase dispersed throughout an aqueous phase, or vice-versa.
    Administration Route(s):
  • Intra-articular - Administration within a joint.
  • Intralesional - Administration within or introduced directly into a localized lesion.
  • Intramuscular - Administration within a muscle.
  • Intrasynovial - Administration within the synovial cavity of a joint.
  • Soft Tissue - Administration into any soft tissue.
  • Sample Package:
    No
    FDA Application Number:
    ANDA201835
    Marketing Category:
    ANDA - A product marketed under an approved Abbreviated New Drug Application.
    Start Marketing Date:
    11-15-2021
    Listing Expiration Date:
    12-31-2024
    Exclude Flag:
    N
    Code Structure:

    The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.

    * Please review the disclaimer below.

    NDC HCPCS Crosswalk

    This crosswalk is intended to help the public understand which drug products (identified by NDCs) are assigned to which HCPCS billing codes.

    NDC 25021-820-05 HCPCS crosswalk information with package details and bill units information.

    NDC Billing CodeHCPCS CodeHCPCS Code Desc.DosagePackage SizePackage QuantityBillable UnitsBillable Units / Pkg
    25021082005J1030Methylprednisolone 40 mg inj40 MG5155

    * Please review the disclaimer below.

    Other Product Packages

    The following packages are also available for this product:

    NDC Package CodePackage Description
    25021-820-101 VIAL in 1 CARTON / 10 mL in 1 VIAL

    * Please review the disclaimer below.

    Frequently Asked Questions

    What is NDC 25021-820-05?

    The NDC Packaged Code 25021-820-05 is assigned to a package of 1 vial in 1 carton / 5 ml in 1 vial of Methylprednisolone Acetate, a human prescription drug labeled by Sagent Pharmaceuticals. The product's dosage form is injection, suspension and is administered via intra-articular; intralesional; intramuscular; intrasynovial; soft tissue form.

    Is NDC 25021-820 included in the NDC Directory?

    Yes, Methylprednisolone Acetate with product code 25021-820 is active and included in the NDC Directory. The product was first marketed by Sagent Pharmaceuticals on November 15, 2021 and its listing in the NDC Directory is set to expire on December 31, 2024 if the product is not updated or renewed by the manufacturer.

    What is the NDC billing unit for package 25021-820-05?

    The contents of this package are billed per "ml or milliliter", products billed per milliliter are usually products measured by liquid volume.

    What is the 11-digit format for NDC 25021-820-05?

    The 11-digit format is 25021082005. The 11-digit billing format might be required by the Centers for Medicare & Medicaid Services (CMS) and other payers in billing claim forms.

    This package code is originally configured in a 5-3-2 segment 10-digit format and by adding a zero within the original NDC package code we can obtain the converted 11-digit format in a 5-4-2 segment configuration. The table below shows the 11-digit code conversion:

    10-Digit Format10-Digit Original Code11-Digit Format11-Digit Code
    5-3-225021-820-055-4-225021-0820-05